# Relaxed multi-module round-2 P1-Q audit

> Date: 2026-06-21
> Scope: P1 concrete-module boundary follow-up focused on `ASD-0743`.
> Rule: only high-confidence changes supported by first-hand paper evidence, official project assets, or other authoritative first-hand sources are written back to the master list and Notes.

## 本轮结论

本轮关闭 1 条 `06 / 07` 高压边界记录：

| ID | Title short | Sources checked | Decision | Note action |
|---|---|---|---|---|
| `ASD-0743` | STAT | Crossref DOI abstract `10.64898/2026.05.01.722244`; official `STAT-agent` README; official `STAT-PaperRepro` benchmark `queries.json` / `DATA.md`; official `STAT-PaperRepro/colorectal_cancer/README.md` | accepted `scientific_object_modules=06;07`; keep `primary_module_for_filing=06` | revised `Notes/06_Life_Sciences/Chen_2026_STAT_Spatial_Transcriptomics.md` |

## Evidence summary

### `ASD-0743` STAT: A multi-agent framework for integrated and interactive spatial transcriptomics analysis

- Agent evidence: the official abstract explicitly presents STAT as a `multi-agent framework`, and the official repository documents a planned, verified, and executed natural-language-driven spatial-omics workflow with persistent state, skill selection, code execution, and interactive review.
- `06` evidence: the stable object remains spatial transcriptomics / spatial omics analysis. The abstract, repo README, dataset note, and benchmark inventory all center on cell-type annotation, cell-cell communication, spatial co-localization, differential expression, pathway enrichment, niche detection, and multi-slice integration across spatial-omics datasets such as human DLPFC, mouse brain cortex, and human breast-cancer tissue.
- `07` evidence: the accessible first-hand evidence goes beyond a disease-labeled dataset name. The Crossref abstract explicitly reports `multi-task spatial analysis of a mixed-resolution breast cancer cohort` and reproduction of key findings from a `published Visium HD colorectal cancer study`. The official benchmark queries for the human breast-cancer dataset include tasks such as `Find cell-cell communication patterns between tumor and immune cells`, `What genes distinguish the tumor regions from the surrounding stroma?`, and `What biological pathways are active in the tumor microenvironment?` The official colorectal-cancer reproduction directory is also a standalone demo path, confirming that cancer-tissue analysis is not incidental background metadata.
- Why the boundary is now closed: unlike cases where only organ/tissue omics datasets are visible, this record exposes explicit oncology-oriented disease objects and tumor-microenvironment analysis tasks in official benchmark and reproduction assets. Under the current relaxed rule, these disease/pathology-style case studies are enough to support independent medical-object coverage even without patient-survival or treatment-ranking endpoints.
- Accepted action: close the `06 / 07` boundary as `06;07`, while keeping `06` as the relaxed primary filing direction because the system's center of gravity is still spatial-omics analysis rather than a broader medical-research workflow.

## Count update

Post-P1-Q relaxed overlay counts increase only in module `07`:

| Scientific object module | Expanded assignment count |
|---|---:|
| `01` | 55 |
| `02` | 37 |
| `03` | 82 |
| `04` | 110 |
| `05` | 35 |
| `06` | 75 |
| `07` | 72 |
| `08` | 3 |
| `09` | 36 |
| `10` | 24 |
| `11` | 35 |

| Metric | Count |
|---|---:|
| Record-level confirmed included-and-classified count | 451 |
| Expanded module assignment count | 562 |
| Independent `01.04` general-method bucket count | 20 |

## Remaining uncertainty

- Direct preprint full-text / PDF access would still help with page-level extraction and richer method / result notes.
- That said, the currently accessible first-hand evidence is already sufficient to land `07` under the project's relaxed object-coverage rule, so this record no longer needs to stay open in the round-2 boundary queue.
